Developement of Stroke Prognosis Predictive Precision Medicine Based on a Digital Twin

Launched by SEYOUNG SHIN · Sep 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to improve care for stroke patients by using advanced technology. The goal is to create a personalized approach to treatment, often called "precision medicine." Researchers will gather a lot of information about patients, including their medical history and daily activities, to better understand how strokes affect people over time. They will then use artificial intelligence (AI) to predict how well patients might recover in the long term.

To join this study, participants need to be adults over 20 years old who have had a stroke between January 2018 and July 2023, and they should have gone through rehabilitation after their stroke. It's important that they can make decisions about their participation on their own. However, individuals with serious health issues or those who have trouble understanding the study cannot join. Participants can expect to contribute to important research that could lead to better treatment options for stroke patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults over 20 years of age with a history of stroke onset between 2018.01.01 to 2023.07.31.
• • Patients who exist rehabilitation medical evaluation after stroke onset
• • Patients who voluntarily decide to participate in this study
• Exclusion Criteria:
• • Those who have severe internal diseases such as unstable conditions of the cardiovascular system, digestive system, respiratory system, endocrine system, etc. and are in poor overall condition.
• • Those who have impaired ability to consent (MMSE score less than 10 points) and not accompanied by a care-giver.
• • In any other cases where the researcher determines that participation in this study is not appropriate.